Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer (Nature Clinical Practice Oncology)

Cancer immunotherapy is presently one of the areas in which major medical breakthroughs are being witnessed, with impressive results reported by several groups. Recently, three articles published in Nature have prodvided new insights into the type of cancers that respond to therapies that lift